Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 4/20 | 0.62 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.47 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.47 |
| ▸ | DRD2 | P14416 | 2/20 | 0.47 |
| ▸ | DRD3 | P35462 | 2/20 | 0.47 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | NPC1L1 | Q9UHC9 | 12/20 | 0.43 |
| ▸ | DRD4 | P21917 | 1/20 | 0.42 |
| ▸ | DDR1 | Q08345 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7999893 | 1.00 | OPRL1 (0.62) | OPRL1OPRM1OPRD1DRD2DRD3 | |
| SCHEMBL7758850 | 0.96 | OPRL1 (0.62) | OPRL1OPRM1OPRD1DRD2DRD3 | |
| SCHEMBL7758844 | 0.96 | OPRL1 (0.62) | OPRL1OPRM1OPRD1DRD2DRD3 | |
| SCHEMBL7760247 | 0.96 | OPRL1 (0.62) | OPRL1OPRM1OPRD1DRD2DRD3 | |
| SCHEMBL7758917 | 0.92 | OPRL1 (0.58) | OPRL1OPRM1OPRD1DRD2DRD3 | |
| SCHEMBL7758921 | 0.92 | OPRL1 (0.58) | OPRL1OPRM1OPRD1DRD2DRD3 | |
| SCHEMBL7757029 | 0.92 | OPRL1 (0.57) | OPRL1OPRM1OPRD1DRD2DRD3 | |
| SCHEMBL7757040 | 0.92 | OPRL1 (0.57) | OPRL1OPRM1OPRD1DRD2DRD3 | |
| SCHEMBL7994124 | 0.91 | OPRL1 (0.63) | OPRL1OPRM1OPRD1DRD2DRD3 | |
| SCHEMBL7757070 | 0.90 | OPRL1 (0.68) | OPRL1OPRM1OPRD1DRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6277991-B1 | FOR TREATMENT OF MIGRAINE, NON-INSULIN DEPENDENT DIABETES MELLITUS, SEPSIS, INFLAMMATION, INCONTINENCE, VASOMOTOR DISTURBANCES SUCH AS HOT FLUSHES OR HOT FLASHES | NOVO NORDISK A/S (DK) | 2001-08-21 | — | — | US | disclosed |